创伤中心收治量对钝性创伤性主动脉损伤治疗策略与结局的影响
基于Aortic Trauma Foundation国际前瞻性多中心注册研究2014–2024年1061例钝性创伤性主动脉损伤患者的回顾性分析,比较 high-volume 与 low-volume 创伤中心的治疗策略和结局。低容量中心对轻微主动脉损伤更常用TEVAR,且院内死亡率、主动脉相关死亡率和住院时间更高;结果支持对轻微损伤采用药物治疗并将患者集中至高容量中心管理。
要点
- 低容量中心对轻微主动脉损伤(SVS I–II级)TEVAR使用率显著高于高容量中心。
- 低容量中心院内死亡率和主动脉相关死亡率更高,住院时间更长。
- 研究支持对轻微主动脉损伤采用药物治疗,并建议患者在高容量中心管理。
核心结论
- 低容量创伤中心管理钝性创伤性主动脉损伤与更高的院内死亡率、主动脉相关死亡率和入路相关并发症相关。
- 这些结局差异似乎与低容量中心对轻微主动脉损伤更高比例采用TEVAR而非药物治疗有关。
- 研究结果支持对轻微主动脉损伤采用药物治疗,并提示钝性创伤性主动脉损伤患者在高容量中心管理可能结局更好。
研究设计与样本
- 回顾性分析Aortic Trauma Foundation国际前瞻性多中心注册研究2014–2024年数据。
- 共纳入48个国际中心的1061例钝性创伤性主动脉损伤患者。
- 暴露因素包括药物治疗、TEVAR和开放修复,按创伤中心容量和时间分层。
- 主要结局为治疗方式、院内死亡率、30天死亡率和主动脉相关院内死亡率。
主要发现
- 高容量中心患者整体损伤严重度评分更高(35.1 vs 33.8;P < .001)。
- 高容量中心SVS I级损伤更常见(32.7% vs 18.0%;P < .001),SVS III级损伤总体最常见。
- 低容量中心TEVAR更常施行(64.9% vs 55.6%;P = .002)且更可能急诊进行。
- 对轻微主动脉损伤(SVS I和II级),低容量中心TEVAR使用率为32.3%,高容量中心为12.4%(P < .001)。
- 低容量中心院内死亡率16.9% vs 12.2%(P = .029),主动脉相关死亡率7.4% vs 2.8%(P < .001),住院时间20.3 vs 16.4天(P ≤ .001)。
关键数值与推荐
- SVS I级损伤在高容量中心占比32.7%,低容量中心占比18.0%(P < .001)。
- 低容量中心对轻微主动脉损伤(SVS I和II级)TEVAR使用率32.3%,高容量中心12.4%(P < .001)。
- 低容量中心院内死亡率16.9%,高容量中心12.2%(P = .029)。
- 低容量中心主动脉相关死亡率7.4%,高容量中心2.8%(P < .001)。
- 低容量中心住院时间20.3天,高容量中心16.4天(P ≤ .001)。
临床怎么用
- 对轻微主动脉损伤(SVS I–II级)应优先考虑药物治疗而非TEVAR。
- 钝性创伤性主动脉损伤患者可考虑集中至高容量创伤中心管理以改善结局。
- 低容量中心应关注TEVAR使用指征,避免对轻微损伤过度干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Management of blunt traumatic aortic injuries (BTAIs) has changed significantly over time. There is now increasing support for medical management of minimal aortic injuries (MAIs; Grades I and II) and thoracic endovascular aortic repair (TEVAR) in more severe injuries (Grades III and IV). Data on real-world management of BTAIs, from medical therapy to surgical intervention, remains limited. Available literature predominately focuses on outcomes after intervention, rather than the spectrum of BTAI care that includes medical management. Furthermore, it remains unclear whether the trauma center volume influences the management and the outcome of patients with BTAIs.We aim to investigate the impact of trauma center volume and temporal treatment patterns on outcomes of patients with BTAIs encompassing medical management and surgical intervention. METHODS: The Aortic Trauma Foundation international prospective multicenter registry was retrospectively analyzed to examine the impact of trauma center volume and temporal treatment patterns on outcomes of patients with BTAIs from 2014 through 2024. Exposures included medical management, thoracic endovascular aortic repair (TEVAR), and open repair, stratified by trauma center volume, and over time. The primary outcomes were treatment modality, in-hospital mortality, 30-day mortality, and aortic-related in-hospital mortality. Secondary outcomes included perioperative complications such as stroke, spinal cord ischemia, cardiac, pulmonary, acute renal failure, extremity ischemia, and access site complications. Results were stratified according to high- or low-volume trauma center status and temporal trends. RESULTS: Among 1061 patients with BTAIs from 48 international centers, there was no significant difference in baseline patient demographics or presenting hemodynamics between those treated at high-volume trauma centers (HVCs) vs low-volume trauma centers (LVCs). The average age of the cohort was 43.5 years, and 75.9% were male. Patients evaluated at HVCs had more concomitant injuries, as determined by a higher overall Injury Severity Score (ISS; 35.1 vs 33.8; P < .001). Society for Vascular Surgery (SVS) Grade I injuries were more common at HVCs (32.7% vs 18.0%; P < .001), whereas SVS Grade III injuries were the most common overall. TEVAR was more frequently performed (LVC, 64.9% vs HVC, 55.6%; P = .002) and were more likely to be conducted emergently at LVCs compared with HVCs. There was an increase in the use of medical management for low-grade BTAIs over time at all centers. Discrepancy in TEVAR utilization was particularly pronounced for MAIs (SVS Grade I and II), with LVCs treating 32.3% of these injuries, compared with 12.4% at HVCs (P < .001). Notably, this correlated with higher in-hospital mortality (16.9% vs 12.2%; P = .029), aortic-related mortality (7.4% vs 2.8%; P < .001), and longer hospital lengths of stay (20.3 vs 16.4 days; P ≤ .001), in patients treated at LVCs compared with HVCs. CONCLUSIONS: Management of BTAIs at LVCs is associated with higher rates of in-hospital, aortic-related mortality, and access-related complications. These outcomes appear to be associated with a higher rate of TEVAR compared with medical management for MAIs at LVCs. These findings support medical management of MAIs and suggest that patients with BTAIs may have better outcomes when managed at HVCs.
引用
- Matthews R, Chou EL, Dubose JJ, et al. Impact of trauma center volume on treatment strategies and outcomes of blunt traumatic aortic injuries. J Vasc Surg. 2026. PMID: 41654034. doi:10.1016/j.jvs.2026.01.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。